The agency said the three-year project will strengthen vaccine quality surveillance in Nigeria through advanced screening technologies, routine laboratory testing and evidence-based research. NAFDAC Director-General, Prof. Mojisola Adeyeye, disclosed this in a statement shared on the agency’s official X handle on Monday. NAFDAC said the grant also expands earlier research by the University of Oxford’s Medicine Quality Research Group and its partners, which successfully adapted advanced scientific techniques to detect degraded and falsified vaccines within supply chains. She added that, as Nigeria’s National Regulatory Authority, NAFDAC would coordinate the project’s implementation in the country by strengthening vaccine quality surveillance and supporting evidence-based regulatory decisions. The agency said the project would also generate critical evidence to support the deployment of screening technologies that verify vaccine quality throughout the supply chain.